GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Dipna Pharmachem Ltd (BOM:543594) » Definitions » Debt-to-Revenue

Dipna Pharmachem (BOM:543594) Debt-to-Revenue : 0.09 (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Dipna Pharmachem Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Dipna Pharmachem's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹21 Mil. Dipna Pharmachem's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹149 Mil. Dipna Pharmachem's annualized Revenue for the quarter that ended in Sep. 2024 was ₹1,812 Mil. Dipna Pharmachem's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 was 0.09.


Dipna Pharmachem Debt-to-Revenue Historical Data

The historical data trend for Dipna Pharmachem's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dipna Pharmachem Debt-to-Revenue Chart

Dipna Pharmachem Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Debt-to-Revenue
0.31 0.40 0.14 0.16 0.12

Dipna Pharmachem Semi-Annual Data
Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only 0.08 0.16 0.12 0.11 0.09

Competitive Comparison of Dipna Pharmachem's Debt-to-Revenue

For the Pharmaceutical Retailers subindustry, Dipna Pharmachem's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dipna Pharmachem's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Dipna Pharmachem's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Dipna Pharmachem's Debt-to-Revenue falls into.


;
;

Dipna Pharmachem Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Dipna Pharmachem's Debt-to-Revenue for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(68.981 + 125.47) / 1643.371
=0.12

Dipna Pharmachem's annualized Debt-to-Revenue for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(21.255 + 149.363) / 1812.476
=0.09

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Sep. 2024) Revenue data.


Dipna Pharmachem Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Dipna Pharmachem's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Dipna Pharmachem Business Description

Traded in Other Exchanges
N/A
Address
A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad, GJ, IND, 380055
Dipna Pharmachem Ltd is engaged in the trading and distribution of a wide range of pharmaceutical raw materials which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The company's product portfolio comprises of Hydrocortisone Acetate, Aceclofenac, Asprin, Levofloxacin, and others.

Dipna Pharmachem Headlines

No Headlines